This is a firm fixed-price purchase order awarded to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services. The contract is for the delivery of specialized cell culture kits, including the STEMDIFF MICROGLIA DIFFERENTIATION KIT, STEMDIFF MICROGLIA MATURATION KIT, and STEMDIFF HEMATOPOETIC KIT, with a total ceiling value of $10,449.66. The contract has an ultimate completion date of April 6, 2025 and does not utilize any small business set-aside designation. Stemcell Technologies Inc. is a key supplier of biological materials, laboratory supplies, and scientific equipment to various federal research agencies, including the NIH, Centers for Disease Control and Prevention, and Food and Drug Administration, supporting critical biomedical research across areas such as infectious diseases, immunology, stem cell research, and translational medicine.
Generated 3/8/25, 9:53 AM